118 related articles for article (PubMed ID: 6974052)
21. Prolongation of canine skin graft survival by deoxycoformycin.
Epstein RB; Fey T; Sarpel S
Transplantation; 1982 Feb; 33(2):208-9. PubMed ID: 7036476
[No Abstract] [Full Text] [Related]
22. Effects of antineoplastic and immunosuppressant drugs on deoxyribonucleic acid-polymerizing enzymes of rat thymus and spleen.
Coleman MS; Hutton JJ
Mol Pharmacol; 1977 Jan; 13(1):122-32. PubMed ID: 299913
[No Abstract] [Full Text] [Related]
23. 2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.
Gray DP; Grever MR; Siaw MF; Coleman MS; Balcerzak SP
Cancer Treat Rep; 1982 Feb; 66(2):253-7. PubMed ID: 6976833
[TBL] [Abstract][Full Text] [Related]
24. Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside.
Lum CT; Sutherland DE; Payne WD; Gorecki P; Matas AJ; Najarian JS
J Surg Res; 1980 Jan; 28(1):44-8. PubMed ID: 6767140
[No Abstract] [Full Text] [Related]
25. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
26. Complete suppression of skin allograft rejection in rats treated with continuous infusion of 2'deoxycoformycin.
Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
Transplantation; 1985 Aug; 40(2):137-42. PubMed ID: 3895617
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
Schramm VL; Baker DC
Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
[TBL] [Abstract][Full Text] [Related]
28. The availability of purines influences both the number of parasites and the splenocyte levels of purine-metabolizing enzymes in trypanosome-infected mice.
Albright JW; Albright JF
Infect Immun; 1988 Apr; 56(4):831-5. PubMed ID: 3126145
[TBL] [Abstract][Full Text] [Related]
29. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM; Henderson JF
Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
[TBL] [Abstract][Full Text] [Related]
30. Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
Yu AL; Mendelsohn J; Matsumoto SS
Adv Exp Med Biol; 1986; 195 Pt A():491-6. PubMed ID: 3487920
[No Abstract] [Full Text] [Related]
31. The effects of adenosine and 2'-deoxycoformycin on sleep and wakefulness in rats.
Virus RM; Djuricic-Nedelson M; Radulovacki M; Green RD
Neuropharmacology; 1983 Dec; 22(12A):1401-4. PubMed ID: 6607425
[TBL] [Abstract][Full Text] [Related]
32. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
Ballow M; Pantschenko AG
Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
[No Abstract] [Full Text] [Related]
33. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
34. Deoxycoformycin toxicity in mice after long-term treatment.
Agarwal RP
Cancer Chemother Pharmacol; 1980; 5(2):83-7. PubMed ID: 6970629
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
Nicholson JK; Gordon DS; McDougal JS
Cell Immunol; 1983 Jul; 79(2):320-33. PubMed ID: 6347398
[TBL] [Abstract][Full Text] [Related]
36. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
Romo A; Lorente F; Salazar V
Allergol Immunopathol (Madr); 1988; 16(4):243-7. PubMed ID: 3265855
[TBL] [Abstract][Full Text] [Related]
37. Tight binding inhibitors--VIII. Studies of the interactions of 2'-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system.
Rogler-Brown T; Parks RE
Biochem Pharmacol; 1980 Sep; 29(18):2491-7. PubMed ID: 6968561
[No Abstract] [Full Text] [Related]
38. Low-dose deoxycoformycin in the treatment of hairy cell leukemia.
Kraut EH; Bouroncle BA; Grever MR
Blood; 1986 Nov; 68(5):1119-22. PubMed ID: 3490287
[TBL] [Abstract][Full Text] [Related]
39. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration.
Phillis JW; O'Regan MH
Brain Res Bull; 1989 Mar; 22(3):537-40. PubMed ID: 2785431
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of coformycin and 2'-deoxycoformycin, and substrate and inhibitor properties of the nucleosides and nucleotides in several enzyme systems.
Bzowska A; Lassota P; Shugar D
Z Naturforsch C Biosci; 1985; 40(9-10):710-4. PubMed ID: 3002059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
